Management of drooling in children with cerebral palsy: A French survey.
作者： E. Chaléat-Valayer , M. Porte , K. Buchet-Poyau , F. Roumenoff-Turcant , M.C. D'Anjou
DOI: 10.1016/J.EJPN.2016.04.010
关键词:
摘要: Abstract Aim To characterise children with cerebral palsy (CP) and pathological drooling in France, to describe care pathways, assessment treatment. Method A transversal, observational, descriptive survey of the practices opinions 400 health professionals potentially involved CP, was carried out nationally across France 2013. Results The response rate 36%. Seventy-five questionnaires were returned analysed (52%). small proportion specifically treated for ( most common treatment oro-facial rehabilitation (95% professionals), followed by anticholinergic drugs (Scopolamine®) (94%) botulinum toxin injections (BT) (66%) surgery (34%). Scopolamine considered be less effective than BT have more side effects. Conclusion CP is likely underestimated under France. There a lack knowledge regarding tools. Aside from rehabilitation, current practice prescribe medication as first-line treatment, however consider that has
sci-hub.se 参考文章(31)
SUSAN M REID, HILARY M JOHNSON, DINAH S REDDIHOUGH, The Drooling Impact Scale: a measure of the impact of drooling in children with developmental disabilities. Developmental Medicine & Child Neurology. ,vol. 52, ,(2010) , 10.1111/J.1469-8749.2009.03519.X
ARTHUR RT SCHEFFER, CORRIE ERASMUS, KAREN VAN HULST, JACQUES VAN LIMBEEK, JAN J ROTTEVEEL, PETER H JONGERIUS, FRANK JA VAN DEN HOOGEN, Botulinum toxin versus submandibular duct relocation for severe drooling. Developmental Medicine & Child Neurology. ,vol. 52, pp. 1038- 1042 ,(2010) , 10.1111/J.1469-8749.2010.03713.X
KATE RODWELL, PRIYA EDWARDS, ROBERT S WARE, ROSLYN BOYD, Salivary gland botulinum toxin injections for drooling in children with cerebral palsy and neurodevelopmental disability: a systematic review. Developmental Medicine & Child Neurology. ,vol. 54, pp. 977- 987 ,(2012) , 10.1111/J.1469-8749.2012.04370.X
SUSAN M REID, JENNIFER MCCUTCHEON, DINAH S REDDIHOUGH, HILARY JOHNSON, Prevalence and predictors of drooling in 7- to 14-year-old children with cerebral palsy: a population study. Developmental Medicine & Child Neurology. ,vol. 54, pp. 1032- 1036 ,(2012) , 10.1111/J.1469-8749.2012.04382.X
Chang, Lin, Tung, Chang, The association of drooling and health-related quality of life in children with cerebral palsy. Neuropsychiatric Disease and Treatment. ,vol. 8, pp. 599- 604 ,(2012) , 10.2147/NDT.S39253
M. T. B. R. Santos, M. C. D. Ferreira, M. F. Leite, R. O. Guaré, Salivary parameters in Brazilian individuals with cerebral palsy who drool. Child Care Health and Development. ,vol. 37, pp. 404- 409 ,(2011) , 10.1111/J.1365-2214.2010.01176.X
D. Reddihough, C. E. Erasmus, H. Johnson, G. M. W. McKellar, P. H. Jongerius, Botulinum toxin assessment, intervention and aftercare for paediatric and adult drooling: international consensus statement. European Journal of Neurology. ,vol. 17, pp. 109- 121 ,(2010) , 10.1111/J.1468-1331.2010.03131.X
B R Johnstone, S M Reid, B Rawicki, C Westbury, D S Reddihough, Randomized trial of botulinum toxin injections into the salivary glands to reduce drooling in children with neurological disorders Developmental Medicine & Child Neurology. ,vol. 50, pp. 123- 128 ,(2008) , 10.1111/J.1469-8749.2007.02015.X
Arthur R. T. Scheffer, Corrie Erasmus, Karen van Hulst, Jacques van Limbeek, Peter H. Jongerius, Frank J. A. van den Hoogen, Efficacy and Duration of Botulinum Toxin Treatment for Drooling in 131 Children Archives of Otolaryngology-head & Neck Surgery. ,vol. 136, pp. 873- 877 ,(2010) , 10.1001/ARCHOTO.2010.147
Mélanie Porte, Emmanuelle Chaléat-Valayer, Karine Patte, Marie-Charlotte D'Anjou, Christophe Boulay, Isabelle Laffont, Relevance of intraglandular injections of Botulinum toxin for the treatment of sialorrhea in children with cerebral palsy: A review European Journal of Paediatric Neurology. ,vol. 18, pp. 649- 657 ,(2014) , 10.1016/J.EJPN.2014.05.007